Transplant Delivers Durable POEMS Control

Company GEMMAC (Catalan Group for the Study of Multiple Myeloma and Amyloidosis) Event Type Peer-Reviewed Publication (Multicenter Retrospective Cohort) Platform Autologous Stem-Cell Transplantation (High-Dose Melphalan) Indication POEMS Syndrome Summary A same-day peer-reviewed multicenter study followed 40 patients with POEMS syndrome treated at nine Catalan referral…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *